Introduction to Restoration of Reproductive Potential
The inability to conceive places a heavy psychological burden on individuals. The disruption of the reproductive system creates a fracture in one’s personal and social life. Of all of the infertility issues in the world, Male Infertility is one of the leading causes. Male patients, in particular, may experience a long delay in the treatment due to the emotional and psychological burden associated with infertility. Current therapeutic protocols are insufficient to restore the cellular infrastructure. Therefore, novel therapeutic solutions are imperative to the medical community in order to restore the fundamental functions of damaged tissues. Regeneration of spermatogenesis is one of such interventions. Treatment at a specialized Stem Cell Clinic also means that patients will be offered therapeutic solutions that integrate innovative procedures, which aim to repair reproductive tissues. The direct application of UC-MSCs on Male Infertility may offer the value of restoration as a new cellular infrastructure in the context of reproductive health.
Biological Mechanisms at The Cellular Level
In order to apprehend the efficacy of a Male Infertility treatment at a Stem Cell Clinic, one must analyze the cellular interactions and their mechanisms. UC-MSCs rely heavily on layered networks of paracrine signaling systems instead of direct cellular substitution. These cells have the ability to secrete a wide variety of trophic factors known as the secretome. This secretome comprises of a variety of cytokines, chemokines, and extracellular vesicles which lead to significant alterations to the microenvironment. Following administration, the bioactive molecules lead to a suppression of local inflammatory responses which would otherwise inhibit the proliferation of spermatogonial stem cells. The secreted biological factors help endogenous tissue repair by stimulating angiogenesis in the seminiferous tubules. The formation of blood vessels further helps in the provision of necessary nutrients. These regenerative cells also help mitigate oxidative stress through the paracrine release of antioxidants. This ongoing release of biological factors creates a niche that is needed for the compromised testicular tissues to rehabilitate and restructure. The cellular interactions of the paracrine signaling also involves the sustained release of growth factors that stimulate neighboring Leydig cells and as a result lead to the restoration of testosterone synthesis. Finally, the cellular interactions are capped with the transfer of vesicles that are rich in extracellular material and help halt necrosis.
Figure 1: Biological Mechanisms of Stem Cell treatment for Male Infertility
Limitations of Standard Medical Interventions
Current practices for managing Male Infertility outside of a Stem Cell Clinic are a mixture of suboptimal medical and surgical interventions. For example, the pituitary-gonadal axis is targeted with the use of hormones, and the main surgical intervention focuses on improving the drainage of the testes. When all else fails, reproductive assistance is the only remaining option. This form of assisted technology circumvents the natural selection of fertilization by forcing the process. However, the leading methods have large shortcomings. Many of the hormonal treatments are hit or miss in improving the production of sperm and can have systemic side effects. There are risks that come along with surgical interventions. Lastly, reproductive assisted technologies merely go around the natural methods that the body has in place and do not repair the reproductive systems that have suffered. There are many ongoing cellular degenerative processes that the current methods are ignoring and that restorative approaches utilizing UC-MSCs need to focus on.
Rationale for Utilizing Alternative Interventions
The use of cellular therapeutics aims to resolve biological issues that remain after traditional therapies. In the case of Male Infertility, the choice to use UC-MSCs is based on their high proliferation and unique immunomodulation. UC-MSCs are low in immunogenicity as they do not express class II human leukocyte antigens. Therefore, their use in an allogeneic setting is possible without the need for a problematic immunosuppressive regimen. In a controlled Stem Cell Clinic environment, these stem cells exhibit the ability to home to sites of injury. The cells migrate to areas of tissue damage through the cues of inflammatory signals released by injured testicular cells. Once they arrive at the injury site, they prevent the apoptosis of the remaining Leydig and Sertoli cells. This is crucial as it maintains the hormonal balance needed for the maturation of sperm. This form of therapy is dynamic in that its secretory profile and activity adapt to the needs of the necrotic tissue. Because of this, a strong, viable dose of therapy is delivered to the area of need quickly. This unique, effective, and optimal combination of factors is an ideal therapeutic profile.
Emerging trends in improving therapeutic options in Thailand
Due to the combination of a stable healthcare system and a flexible regulatory system, Thailand is quickly becoming a leader in advanced cellular therapeutics. The government has taken steps to stimulate biomedical research and the translation of laboratory research to patients. The project of creating a Stem Cell Clinic in this region would mean access to world class laboratory services, which could support complex cell processing. Thailand has fully recruited medical specialists in the field of reproductive endocrinology, and patients who have Male Infertility in Thailand can rely on a care model framework designed on advanced biotechnology and supported by a complete therapeutic framework. In combination with future trends, this will mean that different therapies based on the use of umbilical cord mesenchymal stem cells (UC-MSCs) will become foundational therapies in the region.